ALDH7A1 and Parkinson disease: Numerous studies indicate that PDE inhibitors present a wide range of pharmacological activities, including anti-inflammatory, anti-oxidant, vasodilator, anti-cancer, and neuroprotective properties, suggesting that they can be used as potential drugs for the treatment of respiratory tract diseases, cardiovascular system diseases, depression, dementia, and PD.44–47